You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mucinous ovarian cancers

Showing 1 - 25 of 8,814
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

Not yet recruiting
  • Endometrioid Cancer
  • +3 more
  • VS-6766 + defactinib
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 19, 2022

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)

Recruiting
  • Mucinous Ovarian Cancer
  • +2 more
  • Bevacizumab + modified FOLFIRINOX
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Dec 25, 2022

Ovarian Cancer Trial in Houston (Cytoreductive surgery)

Recruiting
  • Ovarian Cancer
  • Cytoreductive surgery
  • Houston, Texas
    MD Anderson Cancer Center
Jul 28, 2022

High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

Not yet recruiting
  • High Grade Serous Ovarian Cancer (HGSOC)
  • FAPI PET CT
  • (no location specified)
Jul 20, 2023

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
May 12, 2023

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • New Haven, Connecticut
  • +1 more
Jan 11, 2023

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

Terminated
  • Ovarian Cancer
  • +21 more
  • Exercise Counseling
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 6, 2022

Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)

Not yet recruiting
  • Ovarian Carcinoma
  • Sacituzumab govitecan
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 31, 2023

Endometrial Cancer, Ovarian Cancer Trial in Sherbrooke (Loperamide Pill, hyoscine-n-butylbromide)

Recruiting
  • Endometrial Cancer
  • Ovarian Cancer
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Oct 31, 2022

Oocyte Freezing for Fertility Preservation in Benign Ovarian

Recruiting
  • Endometriosis
  • +2 more
    • Lille, France
      Hop Jeanne de Flandre Chu Lille
    Dec 13, 2022

    Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

    Active, not recruiting
    • Fallopian Tube Clear Cell Adenocarcinoma
    • +22 more
    • Laboratory Biomarker Analysis
    • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Oct 7, 2022

    Breast Cancer, Ovarian Cancer, Pancreatic Cancer Trial in United States (Standard Genetic Counseling, Educational Video)

    Active, not recruiting
    • Breast Cancer
    • +3 more
    • Standard Genetic Counseling
    • Educational Video
    • Boston, Massachusetts
    • +5 more
    Jan 25, 2023

    Ovarian Cancer, Recurrent Ovarian Carcinoma Trial in Shibin Al Kawm (secondary cytoreductive surgery, Chemotherapy)

    Withdrawn
    • Ovarian Cancer
    • Recurrent Ovarian Carcinoma
    • Shibīn Al Kawm, Menoufia, Egypt
      Menoufia University, Faculty of medicine
    Apr 9, 2022

    Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

    Not yet recruiting
    • Platinum-resistant Ovarian Cancer
    • +6 more
    • Pegylated Liposomal Doxorubicin + SL-172154
    • Mirvetuximab + SL-172154
    • (no location specified)
    Jul 29, 2022

    Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen

    Not yet recruiting
    • Metastatic Endometrial Carcinoma
    • +7 more
    • Biopsy
    • +5 more
    • (no location specified)
    Jan 18, 2023

    Liquid Biopsies and Tumor Molecular Profiling in Predicting

    Recruiting
    • Endometrial Clear Cell Adenocarcinoma
    • +5 more
    • Biospecimen Collection
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 3, 2022

    Ovarian Cancer, Ovarian Carcinoma, Ovarian Cancer Stage IV Trial in Boston (Exercise, Attention Control)

    Recruiting
    • Ovarian Cancer
    • +6 more
    • Exercise
    • Attention Control
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    May 4, 2022

    Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

    Not yet recruiting
    • Advanced Solid Tumor
    • +18 more
    • (no location specified)
    Aug 10, 2022

    Ovarian Carcinoma Trial in France (Experimental arm)

    Active, not recruiting
    • Ovarian Carcinoma
    • Experimental arm
    • Dijon, Centre Georges François Leclerc, France
    • +6 more
    Mar 29, 2022

    Breast Cancer, Ovarian Cancer Trial in Germany (Fasting, Vegan)

    Active, not recruiting
    • Breast Cancer
    • Ovarian Cancer
    • Fasting
    • Vegan
    • Freiburg im Breisgau, Baden-Württemberg, Germany
    • +7 more
    Dec 12, 2022

    SCCOHT, Ovarian Clear Cell Tumor, Ovarian Endometrioid Adenocarcinoma Trial in Scottsdale (SP-2577, Pembrolizumab)

    Withdrawn
    • SCCOHT
    • +3 more
    • Scottsdale, Arizona
      HonorHealth Research Institute
    Feb 11, 2022

    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine plus Bevacizumab, Bevacizumab)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • New Orleans, Louisiana
    • +3 more
    Dec 16, 2022